Patent 11834488 was granted and assigned to Shattuck Labs on December, 2023 by the United States Patent and Trademark Office.
The present invention relates, in part, to, chimeric proteins which include the extracellular domain of V-set and immunoglobulin domain-containing protein 8 (VSIG8) and their use in the treatment of diseases, such as immunotherapies for cancer and/or inflammatory diseases.